Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
157 USD | -6.49% | -7.60% | -12.38% |
05-21 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
05-14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.38% | 17.56B | |
+11.36% | 115B | |
+12.77% | 106B | |
-4.31% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-40.50% | 17.32B | |
+7.41% | 14.03B | |
+33.04% | 12.13B | |
-34.05% | 7.77B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene : Russia Approves BeiGene's Cancer Medicine for Treatment of Mantle Cell Lymphoma